Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Threat to value of CE-marking: Eucomed wants EU strategy counterfeiting

This article was originally published in Clinica

Executive Summary

A strategy to prevent counterfeiting and piracy in medical device trade is essential, European medical technology association, Eucomed, says. The association is concerned that if this issue is not tackled, there will be a real threat to the value of the CE mark and that EU R&D will be discouraged. A legal framework is necessary that allows quick and effective action to eliminate counterfeited products from the market place and the industry must support the latest initiatives that are currently being actively pursued by the European Commission in this respect, the association asserts.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT050736

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel